Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

JBJS reviews·2026
Same author

Do Patients Who Undergo Conversion of Failed Osteoarticular Allografts to Megaprostheses Have Worse Outcomes Than Patients Treated With Primary Megaprostheses at Initial Resection?

Clinical orthopaedics and related research·2026
Same author

Inhibition of CDK9 sensitizes multidrug resistant ovarian cancer cells to paclitaxel.

Scientific reports·2026
Same author

Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression.

Biomolecules·2026
Same author

The IlluminOss photodynamic bone stabilization system: novel technology with broad application in orthopaedic fracture fixation.

Expert review of medical devices·2026
Same author

Cervical spine chordomas: surgical outcome assessment in a multicenter cohort from the Primary Tumor Research and Outcomes Network.

Journal of neurosurgery. Spine·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.2K

Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.

Jie Zhao1, Dylan C Dean2, Francis J Hornicek2

  • 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, China; Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA; Department of Orthopaedic Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, 250031, China.

Cancer Letters
|January 29, 2020
PubMed
Summary

Next-generation sequencing (NGS) reveals new osteosarcoma (OS) biomarkers and therapeutic targets, advancing personalized medicine. This technology aids in understanding OS progression and metastasis for improved patient outcomes.

Keywords:
BiomarkerLung metastasisOsteosarcomaTargeted therapyWhole genome sequencing

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

4.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K

Area of Science:

  • Oncology
  • Genomics
  • Biomarker Discovery

Background:

  • Osteosarcoma (OS) is a primary bone cancer with poor survival rates, often due to lung metastasis.
  • Current treatments have plateaued, necessitating novel therapeutic strategies.
  • Previous technologies limited the identification of crucial OS biomarkers and therapeutic targets.

Purpose of the Study:

  • To review recent advances in next-generation sequencing (NGS) for osteosarcoma (OS) therapy.
  • To highlight how NGS has improved the understanding of OS progression and metastasis.
  • To discuss the role of NGS in advancing personalized medicine for OS patients.

Main Methods:

  • Utilizing large-scale next-generation sequencing (NGS) studies.
  • Analyzing somatic mutations and copy number changes in OS.
  • Comparing primary and matched pulmonary metastatic tumor tissues using NGS.

Main Results:

  • NGS has identified numerous somatic mutations and copy number alterations linked to OS progression and metastasis.
  • Genome-informed pathways and candidate genes for pre-clinical targeting have been expanded.
  • Novel prognostic biomarkers for OS have been discovered through comparative NGS analyses.

Conclusions:

  • NGS is revolutionizing osteosarcoma (OS) research by uncovering new biomarkers and therapeutic targets.
  • This technology facilitates a deeper understanding of OS metastasis.
  • NGS is paving the way for more personalized and effective OS therapies.